• Senolytic Effects of L. plantarum DS0037 Nanovesicles in Agi

  2026-05-26

  The referenced study identifies exosome-like nanovesicles from Lactobacillus plantarum DS0037 as potent senolytic and senomorphic agents capable of selectively targeting senescent cells and modulating skin aging pathways. These findings highlight the translational potential of microbial nanovesicle systems in anti-aging research and cosmetic development.

• Z-WEHD-FMK: Precision Caspase Inhibition for Pyroptosis Rese

  2026-05-26

  This thought-leadership article examines the mechanistic underpinnings and translational opportunities afforded by Z-WEHD-FMK, an irreversible inhibitor of inflammatory caspases. By integrating recent findings on caspase-1 regulation and pyroptotic cell death in cancer, we provide strategic guidance for translational researchers seeking to dissect and modulate inflammatory cell death in disease models. The article contextualizes Z-WEHD-FMK within the evolving landscape of apoptosis and inflammation research, referencing both benchmark protocols and new mechanistic insights, while addressing practical considerations for experimental design.

• Nucleoside-Modified mRNA Vaccines: Protection Against MERS-C

  2026-05-25

  This study demonstrates that nucleoside-modified mRNA encoding the MERS-CoV spike protein receptor-binding domain (RBD) elicits broadly neutralizing antibodies and protects mice from MERS-CoV infection. The findings highlight the critical role of RNA modification in vaccine efficacy and durability, offering translational insights for mRNA vaccine design against emerging coronaviruses.

• Cediranib (AZD2171): Precision Control of Angiogenesis in Ca

  2026-05-25

  Explore how Cediranib (AZD2171) enables mechanistically refined analysis of angiogenesis and tumor signaling for cancer research. This article details its unique action, assay optimization, and the evolving standards for in vitro drug evaluation.

• Lactate-GPR81/FARP1 Axis Drives Insulin-Independent Glucose

  2026-05-24

  This study elucidates a lactate-activated GPR81/FARP1 signaling pathway that enables skeletal muscle to uptake glucose independently of insulin. The findings reveal new molecular targets for metabolic disease management and suggest translational strategies for disorders such as diabetes.

• VP26–Host Actin–Myosin II Interactions Regulate DEV Prolifer

  2026-05-23

  This study identifies the host actin–myosin II network as a critical regulator of duck enteritis virus (DEV) proliferation through a proteomics screen for cellular targets of viral protein VP26. By characterizing protein interactions and using small-molecule inhibitors, the research offers new mechanistic insights and practical avenues for dissecting cytoskeletal contributions to viral infection.

• Applied Angiotensin II: Protocols, Pitfalls, and Vascular In

  2026-05-22

  Harness the power of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) to model hypertension, vascular remodeling, and aortic aneurysm with precision. Learn how to optimize experimental workflows and translate pathophysiological findings—like NAD+ deficiency in smooth muscle—into actionable assay designs.

• Wnt/β-catenin-Driven sPD-L1 Suppresses CD8+ T Cells in Gliom

  2026-05-22

  This study uncovers that glioma cells utilize the Wnt/β-catenin pathway to produce soluble PD-L1 (sPD-L1), which impairs CD8+ T cell function and is linked to poor clinical outcomes. The findings highlight sPD-L1 as a promising prognostic biomarker and therapeutic target, offering new insights for immunotherapy optimization in glioma.

• E-64d: Advanced Insights into Calpain Inhibition and Cellula

  2026-05-21

  Explore the unique mechanism and research applications of E-64d, a membrane-permeable cysteine protease inhibitor. This article analyzes its role in calpain inhibition, apoptosis, and neuroprotection, highlighting innovations in assay design and differentiating from traditional perspectives.

• S-acylation Controls NLRP3 Inflammasome Recruitment to the G

  2026-05-21

  This study reveals that S-acylation of the conserved cysteine 130 residue in NLRP3 acts as a nigericin-sensitive switch, regulating the receptor's recruitment to the Golgi apparatus and thus its activation. The findings provide a mechanistic link between Golgi membrane dynamics and inflammasome signaling, with implications for understanding inflammatory responses and disease pathogenesis.

• WY-14643 (Pirinixic Acid): Selective PPARα Agonist in Metabo

  2026-05-20

  WY-14643 (Pirinixic Acid) is a highly selective PPARα agonist that modulates lipid metabolism, inflammation, and insulin sensitivity. It exhibits dual PPARα/γ activity at low micromolar concentrations and is widely used in metabolic and inflammation research. Its robust efficacy and physicochemical profile make it a standard tool for probing PPAR-mediated pathways.

• Bisphenol A Exposure Drives AAA via Vascular Inflammatory Pa

  2026-05-20

  This study establishes a mechanistic framework linking environmental bisphenol A (BPA) exposure to abdominal aortic aneurysm (AAA) development, integrating cross-species modeling and multi-omics analyses. The findings reveal that BPA promotes AAA through TNF/NF-κB-mediated vascular inflammation and extracellular matrix disruption, offering new targets for risk assessment and intervention.

• Lipo3K Transfection Reagent: Reliable Delivery for Difficult

  2026-05-19

  This article addresses practical laboratory challenges in nucleic acid delivery, focusing on the performance and workflow advantages of Lipo3K Transfection Reagent (SKU K2705) for gene expression and RNA interference studies. Drawing on quantitative evidence and scenario-based analysis, it demonstrates how Lipo3K enables consistent, low-toxicity transfection, even in difficult-to-transfect cell lines.

• Angiotensin II in Translational Research: Mechanisms, Models

  2026-05-19

  This thought-leadership article offers mechanistic insight and strategic guidance for translational researchers leveraging Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in cardiovascular and renal disease modeling. Integrating evidence-backed protocols, competitive benchmarking, and recent advances in fibrosis research, it outlines actionable frameworks for maximizing experimental rigor and translational impact—anchored by APExBIO’s high-quality Angiotensin II reagent.

• Oleanolic Acid in Nanoliposome Design: Encapsulation Efficie

  2026-05-18

  Explore how Oleanolic acid, a potent triterpenoid, advances antiviral research through nanoliposome encapsulation and inducible nitric oxide synthase induction. This article delivers fresh insights on dual-loaded liposome strategies and assay decision-making.

480 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page